ASXL1 and acute myeloid leukemia: Among these 8 samples, all of the CNAs present in a majority of the cells identified by COMPASS were also detected by bulk sequencing, except for a gain affecting ASXL1 in sample AML-60-001 (Fig. 4 and Supplementary Fig. 15).